Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
Coronavirus Resource Center



PUBLIC HEALTH RESOURCES



GOVERNMENT RECOMMENDATIONS, DECLARATIONS, AND ORDERS

  • March 31: Essential Business List Update

  • Medical research, development, and clinical trials to be added to Governor's Essential Business List: Life Science Washington has been working with the Governor's office to ensure that essential life science and medical supply chain operations are recognized as essential in the Governor's Stay Home, Stay Healthy Order. The list of essential businesses with life science and medical supply chain exemptions highlighted can be found here

     

    A number of members were concerned that clinical trials and/or essential R&D operations that can’t easily be shut down and restarted may not be covered in the order. To provide clarity, we petitioned to have personnel conducting essential operations related to medical research, development and clinical trials included as essential. 


    We received word late yesterday that these functions do qualify as essential and that the Governor's office has issued updated guidance that includes these functions. New guidance is posted here.


  • March 24: Critical Exemptions for Life Science Organizations Included in Gov. Inslee's "Stay Home, Stay Safe" Policy
  • March 23: Gov. Inslee announces "Stay Home, Stay Healthy" order

BUSINESS FUNDING & RESOURCES

  • Coronavirus Aid, Relief and Economic Security (CARES) Act: The Federal Coronavirus Aid, Relief, and Economic Security (CARES) Act that was passed this week by Congress contains unprecedented funding and resources to help businesses maintain operations and keep employees on the payroll during the COVID-19 outbreak.

  • BIO Summary of CARES Act: is an overview of key provisions in the bill that relate to life science companies

R&D FUNDING AND RESOURCES
  • The Biomedical Advanced Research and Development Authority (BARDA) of the Department of Health and Human Services has been provided with $2B through the CARES Act to invest in research and development of vaccines, therapeutics, and diagnostics to combat COVID-19. BARDA is pursuing the following: vaccines, diagnostics, potential therapeutics, ventilators, immunomodulators or therapeutics targeting lung repair, pre and post-exposure prophylaxis, and respiratory protective devices.

  • BARDA DRIVe Accelerator: BARDAs Division of Research, Innovation, and Ventures (DRIVe) provide technical and financial resources to entrepreneurs whose ideas have the potential to transform emergency preparedness, detection, and response. Life Science Washington Institute has been selected as one of 13 sites in the DRIVe Accelerator Network to help identify relevant researchers and companies and connect them with the DRIVe team. 

  • InfoEd Global, a provider of software that supports the Electronic Research Administration, has compiled a library of COVID-19 funding opportunities and resources.

  • National Science Foundation Request for SBIR/STTR Phase I Proposals Addressing COVID-19:  The Division of Innovation and Industrial Partnerships (IIP) of the Engineering Directorate invites US-based small businesses to submit Phase I proposals focused on the development and deployment of new technologies, products, processes, and services with the ability to respond to the COVID-19 crisis. 

  • HHS EZ-BAA for Diagnostics: HHS announced an Easy Broad Agency Announcement (EZ-BAA) for development of COVID-19 diagnostics. Solicitation BAA-20-100-SOL-0002

  • FDA Template for Diagnostics EUA: FDA has developed a COVID-19 Emergency Use Authorization (EUA) template for diagnostic developers, available upon request. Sponsors interested in potential Emergency Use Authorization (EUA) for tests to detect COVID-19 may contact CDRH-EUA-Templates@fda.hhs.gov. COVID-19 molecular assays for mature, FDA-cleared, widely placed devices are of great interest to the Agency.
     
  • Gates-Wellcome Trust-Mastercard COVID-19 Therapeutics Accelerator: In March 2020, The Bill & Melinda Gates Foundation, the Wellcome Trust, and Mastercard announced $125 million in seed funding to accelerate the development of therapeutics for COVID-19. The accelerator aims to identify, assess,develop, and scale up treatments.

HR RESOURCES

HOW YOU CAN HELP
  • Donate Personal Protective Equipment: The State of Washington is seeking to fill shortages of specific personal protective equipment (PPE) and infection-control products.
  • Give BloodBlood Supply Hits Emergency Level Due to Coronavirus Concerns. The increase in COVID-19 cases in Seattle and surrounding counties has led to a shortage in blood products due to a decline in donations. Make an appointment to donate blood.
  • Medical Volunteers Needed: King County Department of Health needs medical volunteers. Medical experts in our community can make a difference now to save lives. Simply email hmac.03@kingcounty.gov with name, phone, medical background, and availability to be assigned accordingly.
  • Contribute: The King County Medical Society (KCMS) in partnership with the Expedia Group is responding to the growing needs of PPE. Partnering with local garment manufacturers, and professional tailors and sewers, to quickly and effectively produce needed equipment for our frontline health care workers. Donate today just for $25 for a single PPE kit (mask, gown, and cap). If employers have a matching gift program, please contact Nancy L. Belcher at nbelcher@kcmsociety.org
  • Donations to UW: Gifts are urgently needed to ramp up COVID-19 testing, provide care for the most vulnerable, coordinate the state's emergency response, support research, and provide lifesaving equipment and resources to ensure the health and well-being of UW patients and clinical teams.
  • Stay home! Stop the Spread! Save Lives!

LIFE SCIENCE WASHINGTON COMPANIES RESPOND
  • The latest data analysis from the University of Washington's IMHE (Institute for Health Metrics and Evaluation) predicts WA is near its pandemic peak. 
    Read More


  • CytoDyn in Vancouver and AGC Biologics in Bothell, have been FDA cleared to begin Phase II trials using an HIV drug for treating COVID-19 patients.
    Read More

  • Local ventilator manufacturer, Ventec Life Systems, Inc., jumps in to fix the biggest supply and demand problem of the Coronavirus pandemic by joining with small businesses and huge multinational corporation General Motors, to bring hundreds of thousands of ventilators to market fast.
    Listen to Podcast

Membership Management Software Powered by YourMembership  ::  Legal